The Leishmaniasis Model

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Methods in Microbiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0580-9517(02)32102-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Single gene control of resistance to cutaneous leishmaniasis in mice

  2004cited by this paper
• Arginase I induction in macrophages, triggered by Th2‐type cytokines, supports the growth of intracellular Leishmania parasites

  2002cited by this paper
• The immunology of susceptibility and resistance to Leishmania major in mice

  2002cited by this paper
• Nitric oxide and the immune response

  2001cited by this paper
• IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.

  1999cited by this paper
• Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL‐4 during Leishmania major infection

  1999cited by this paper
• Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions

  1998cited by this paper
• Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.

  1998cited by this paper
• Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.

  1997cited by this paper
• IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

  1997cited by this paper
• Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice.

  1997cited by this paper
• A simple method for quantifying Leishmania in tissues of infected animals.

  1997cited by this paper
• Susceptibility to Leishmania major Infection in Interleukin-4-Deficient Mice

  1996cited by this paper
• Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge

  1996cited by this paper
• Molecular and immune mechanisms in the pathogenesis of cutaneous leishmaniasis

  1996cited by this paper
• Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response

  1996cited by this paper
• Vaccine: the only hope to control leishmaniasis.

  1996cited by this paper
• Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.

  1996cited by this paper
• Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines

  1995cited by this paper
• The regulation of immunity to Leishmania major.

  1995cited by this paper
• Altered immune responses in mice lacking inducible nitric oxide synthase

  1995cited by this paper
• Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam.

  1995cited by this paper
• Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.

  1995cited by this paper
• NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines.

  1994cited by this paper
• Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response

  1994cited by this paper
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• Immunology of leishmaniasis.

  1993cited by this paper
• Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH.

  1993cited by this paper
• The lipophosphoglycan of Leishmania parasites.

  1992cited by this paper
• IL-4 induces a Th2 response in Leishmania major-infected mice.

  1992cited by this paper
• Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

  1992cited by this paper
• Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.

  1991cited by this paper
• Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages.

  1991cited by this paper
• Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

  1990cited by this paper
• A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites.

  1990cited by this paper
• Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis.

  1990cited by this paper
• A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.

  1989cited by this paper
• Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

  1988cited by this paper
• Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity.

  1988cited by this paper
• Experimentally induced cutaneous leishmaniasis: are L3T4+ T cells that promote parasite growth distinct from those mediating resistance?

  1988cited by this paper
• Identification of a monoclonal antibody specific for a murine T3 polypeptide.

  1987cited by this paper
• The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid.

  1987cited by this paper
• Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation

  1987cited by this paper
• Limiting Dilution Assays for the Separation, Characterization, and Quantitation of Biologically Active Particles and Their Clonal Progeny

  1987cited by this paper
• Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin

  1986cited by this paper
• Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1

  1985cited by this paper
• A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

  1985cited by this paper
• Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.

  1985cited by this paper
• Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.

  1985cited by this paper
• Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model.

  1984cited by this paper
• Identification of an infective stage of Leishmania promastigotes.

  1984cited by this paper
• Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Cell Separation: Methods and Selected Applications

  1983cited by this paper
• Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis

  1983cited by this paper
• Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.

  1982cited by this paper
• Systemic infection of Leishmania tropica (major) in various strains of mice.

  1981cited by this paper
• Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

  1981cited by this paper
• Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to leishmania tropica

  1981cited by this paper
• Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.

  1976cited by this paper
• Cell propagation on films of polymeric fluorocarbon as a means to regulate pericellular pH and pO2 in cultured monolayers

  1971cited by this paper

• Quinine and chloroquine: potential preclinical candidates for the treatment of tegumentary leishmaniasis.

  2024cites this paper
• Immunotherapeutic effects of Glycyrrhiza glabra and Glycyrrhizic Acid on Leishmania major‐infection BALB/C mice

  2021cites this paper
• Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model

  2020cites this paper
• Parasite Burden Measurement in the Leishmania major Infected Mice by Using the Direct Fluorescent Microscopy, Limiting Dilution Assay, and Real-Time PCR Analysis

  2020cites this paper
• MicroRNAs Expression Induces Apoptosis of Macrophages in Response to Leishmania major (MRHO/IR/75/ER): An In-Vitro and In-Vivo Study

  2020cites this paper
• Study of the immune adjuvant effect of chitin microparticles on plasma levels of IgG1 and IgG2a during immunization against Leishmania infection in BALB/c mice

  2019cites this paper
• EVALUATION OF NEUROPROTECTIVE EFFECTS OF WEDELOLACTONE AGAINST GLUTAMATE-INDUCED NEUROTOXICITY IN PRIMARY RAT CORTEX NEURONAL CULTURE

  2018cites this paper
• l-Arginine Uptake by Cationic Amino Acid Transporter Promotes Intra-Macrophage Survival of Leishmania donovani by Enhancing Arginase-Mediated Polyamine Synthesis

  2017cites this paper
• Leishmania major strains isolated from distinct endemic areas show diverse cytokine mRNA expression levels in C57BL/6 mice: Toward selecting an ideal strain for the vaccine studies.

  2015cites this paper
• EFFECTS OF TREATMENT WITH CHITIN MICRO-PARTICLES ON LEISHMANIA MAJOR BURDEN IN BALB/C MICE BY USING TITRATION METHOD

  2015cites this paper
• Down-Regulation of T Cell Function by Heat Shock-Induced Excretory Factor of Leishmania Major

  2015cites this paper
• Blocking Junctional Adhesion Molecule C Enhances Dendritic Cell Migration and Boosts the Immune Responses against Leishmania major

  2014cites this paper
• Protein energy malnutrition increases arginase activity in monocytes and macrophages

  2014cites this paper
• Distinct strains of Leishmania major induce different cytokine mRNA expression in draining lymph node of BALB/c mice

  2013cites this paper
• Genotypically distinct strains of Leishmania major display diverse clinical and immunological patterns in BALB/c mice.

  2010cites this paper
• Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis

  2009cites this paper
• Differential impact of l-arginine deprivation on the activation and effector functions of T cells and macrophages

  2008cites this paper
• Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro

  2008cites this paper
• Age-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis

  2008cites this paper
• In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.

  2007cites this paper
• In Vivo Recognition of Ovalbumin Expressed by Transgenic Leishmania Is Determined by Its Subcellular Localization1

  2006cites this paper
• Impairment of Alternative Macrophage Activation Delays Cutaneous Leishmaniasis in Nonhealing BALB/c Mice1

  2006cites this paper
• Its Subcellular Localization Is Determined by Leishmania by Transgenic In Vivo Recognition of Ovalbumin Expressed

  2006cites this paper
• Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo

  2005cites this paper
• in Nonhealing BALB/c Mice Activation Delays Cutaneous Leishmaniasis Impairment of Alternative Macrophage

  2005cites this paper
• Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll‐like receptor 4 in the control of parasite replication

  2004cites this paper
• Leishmania major Parasite Control of Infection with the Protozoan Toll-Like Receptor 4 Contributes to Efficient

  2004cites this paper
• Toll-Like Receptor 4 Contributes to Efficient Control of Infection with the Protozoan Parasite Leishmania major

  2004cites this paper
• Microsatellite analysis of mouse TNF and cypla2 loci for polymorphism: Detection and evaluation of genetic contamination

  2003cites this paper
• Cross‐talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN‐γ production by CD4+ T cells

  2003cites this paper
• Organ‐specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection

  2002cites this paper
• INDUCTION OF TH1 CYTOKINES BY LIVE LOGARITHMIC PROMASTIGOTES OF L. MAJOR

  2001cites this paper